Leslie Zacks is EVP/Chief Legal Compl. Officer at SCIELE PHARMA, INC. (SCRX). They have made 2 open-market trades across 1 company since 2006, most recently 2008-05-19.
CIK 0001314240
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SCRX | SELL · 10b5-1 | 2008-05-19 | 2008-05-19 | $21.71 | $35K | N/A | N/A | N/A |
| SCRX | SELL · 10b5-1 | 2008-01-23 | 2008-01-25 | $22.98 | $114K | N/A | N/A | N/A |
| SCRX | SELL · 10b5-1 | 2007-12-07 | 2007-12-10 | $22.75 | $85K | N/A | N/A | N/A |
| SCRX | SELL · 10b5-1 | 2007-10-31 | 2007-11-02 | $25.25 | $158K | N/A | N/A | N/A |
| SCRX | SELL · 10b5-1 | 2007-08-08 | 2007-08-13 | $23.88 | $65K | N/A | N/A | N/A |
| SCRX | SELL | 2007-01-24 | 2007-01-26 | $23.87 | $40K | N/A | N/A | N/A |
| SCRX | SELL | 2006-10-31 | 2006-11-02 | $21.77 | $136K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.